Search Results - "Salimpour, Pedram"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain by Verrico, Chris D., Wesson, Shonda, Konduri, Vanaja, Hofferek, Colby J., Vazquez-Perez, Jonathan, Blair, Emek, Dunner, Kenneth, Salimpour, Pedram, Decker, William K., Halpert, Matthew M.

    Published in Pain (Amsterdam) (01-09-2020)
    “…Over the last 2 decades, affirmative diagnoses of osteoarthritis (OA) in the United States have tripled due to increasing rates of obesity and an aging…”
    Get full text
    Journal Article
  2. 2

    Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy by Mulhall, J P, Daller, M, Traish, A M, Gupta, S, Park, K, Salimpour, P, Payton, T R, Krane, R J, Goldstein, I

    Published in The Journal of urology (01-11-1997)
    “…We investigated forskolin, a direct adenylate cyclase activator, as an intracavernosal vasoactive agent in management of vasculogenic impotence. Concentration…”
    Get more information
    Journal Article
  3. 3

    A Randomized, Double-Blind, Placebo-Controlled Study of Daily Cannabidiol for the Treatment of Canine Osteoarthritis by Halpert, Matthew, Verrico, Chris, Wesson, Shonda, Konduri, Vanaja, Hofferek, Colby, Vazquez-Perez, Jonathan, Blair, Emek, Dunner, Kenneth, Salimpour, Pedram, Decker, William K

    Published in The Journal of immunology (1950) (01-05-2020)
    “…Abstract Hemp-derived cannabidiol (CBD) is the major non-psychoactive component of cannabis and has been promoted as a potential treatment for a wide variety…”
    Get full text
    Journal Article
  4. 4

    A possible mechanism for alteration of human erectile function by digoxin: inhibition of corpus cavernosum sodium/potassium adenosine triphosphatase activity by Gupta, S, Salimpour, P, Saenz de Tejada, I, Daley, J, Gholami, S, Daller, M, Krane, R J, Traish, A M, Goldstein, I

    Published in The Journal of urology (01-05-1998)
    “…Digoxin use has long been recognized to affect adversely male sexual function but the underlying mechanism is poorly understood. Digoxin is a known inhibitor…”
    Get more information
    Journal Article